Namyang Dairy is reportedly facing the risk of being asked to close down two of its plants in Sejong City over breach of the Act on the Labeling and Advertising of Foods law. It was said that its production facilities may have to be shut for two months.
Temporary factory closure
As per The Korea Times, the cause of violation was the company’s claim of its yogurt’s effectiveness in preventing COVID-19 infection. Namyang Dairy was said to have revealed earlier this week that it has received advance notice of shut down from Sejong City Hall.
The dairy products manufacturer has two factories in this city, and both may be ordered to cease operations in the meantime. The company said that it will inform the public once the local government formally asks them to close the production sites.
"Although the suspension of the business has not been confirmed yet,” a company official said. “We will make a public announcement when Sejong City Hall decides to do so."
Namyang stated that it would try to convince the local government not to impose severe corrective measures. However, if a regulatory action is implemented, Namyang will have to comply with the shutdown order for two factories that produce 38% of the company’s products that include powdered baby formula, yogurts, and other milk.
The cause of violations
Sejong City Hall is giving Namyang up to two weeks to forward appropriate documents and indicate its stance in the matter. Now, the violation of the Act on the Labeling and Advertising of Foods stemmed from the fact that the company said its Bulgaris yogurt has properties that are effective against COVID-19 by the Ministry of Food and Drug Safety (MFDS) said this is a false claim.
The possible shut down, if proven there was really a breach in the said law, comes just days after Namyang’s chairman and CEO resigned from their respective positions. They also apologized for the controversies that its claims had made.
Company chairman Hong Won Sik resigned on Tuesday, May 4, while CEO Lee Kwang Bum stepped down the day before. "We apologize to our customers for causing misunderstanding with our research results," Namyang Dairy also said in a separate statement.


India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



